Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorBADER, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorCOSSIN, Sebastien
IDREF: 197817874
dc.contributor.authorMAILLARD, A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBENARD, Antoine
dc.date.accessioned2020-10-19T07:08:13Z
dc.date.available2020-10-19T07:08:13Z
dc.date.issued2018-10-22
dc.identifier.issn1471-2288en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/11386
dc.description.abstractEnBACKGROUND: Value of information is now recognized as a reference method in the decision process underpinning cost-effectiveness evaluation. The expected value of perfect information (EVPI) is the expected value from completely reducing the uncertainty surrounding the cost-effectiveness of an innovative intervention. Among sample size calculation methods used in cost-effectiveness studies, only one is coherent with this decision framework. It uses a Bayesian approach and requires data of a pre-existing cost-effectiveness study to derive a valid prior EVPI. When evaluating the cost-effectiveness of innovations, no observed prior EVPI is usually available to calculate the sample size. We here propose a sample size calculation method for cost-effectiveness studies, that follows the value of information theory, and, being frequentist, can be based on assumptions if no observed prior EVPI is available. METHODS: The general principle of our method is to define the sampling distribution of the incremental net monetary benefit (DeltaB), or the distribution of DeltaB that would be observed in a planned cost-effectiveness study of size n. Based on this sampling distribution, the EVPI that would remain at the end of the trial (EVPIn) is estimated. The optimal sample size of the planned cost-effectiveness study is the n for which the cost of including an additional participant becomes equal or higher than the value of the information gathered through this inclusion. RESULTS: Our method is illustrated through four examples. The first one is used to present the method in depth and describe how the sample size may vary according to the parameters' value. The three other examples are used to illustrate in different situations how the sample size may vary according to the ceiling cost-effectiveness ratio, and how it compares with a test statistic-based method. We developed an R package (EBASS) to run these calculations. CONCLUSIONS: Our sample size calculation method follows the value of information theory that is now recommended for analyzing and interpreting cost-effectiveness data, and sets the size of a study that balances its cost and the value of its information.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enUSMR
dc.subject.enEMOS
dc.subject.enCIC1401
dc.title.enA new approach for sample size calculation in cost-effectiveness studies based on value of information
dc.title.alternativeBMC Med Res Methodolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s12874-018-0571-1en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30348087en_US
bordeaux.journalBMC medical research methodologyen_US
bordeaux.page113en_US
bordeaux.volume18en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMC%20medical%20research%20methodology&rft.date=2018-10-22&rft.volume=18&rft.issue=1&rft.spage=113&rft.epage=113&rft.eissn=1471-2288&rft.issn=1471-2288&rft.au=BADER,%20C.&COSSIN,%20Sebastien&MAILLARD,%20A.&BENARD,%20Antoine&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée